Thematic area:
Smart Implants and Devices
Product:
A smart, implantable device delivering precise, algorithm guided antihypertensive medication. It integrates real-time wearable blood pressure monitoring with a soft robotic pump for autonomous, closed loop drug dosing.
Market:
Hypertension affects ~70 million adults in the US alone. Closed loop drug delivery systems can achieve reimbursement levels up to $5,000 per patient, creating a strong commercial opportunity in the cardiovascular, digital therapeutics, and chronic disease markets.
Fit:
Uncontrolled hypertension remains a leading global mortality driver. This device directly addresses poor medication adherence and dosing precision. By combining real-time monitoring with automated drug delivery, it delivers a first-in-class personalised therapy solution ready for preclinical and regulatory advancement.
